Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy

Individuals affected by restrictive cardiomyopathy (RCM) often develop heart failure at young ages resulting in early heart transplantation. Familial forms are mainly caused by mutations in sarcomere proteins and demonstrate a common genetic etiology with other inherited cardiomyopathies. Using next‐generation sequencing, we identified two novel missense variants (p.S1624L; p.I2160F) in filamin‐C (FLNC), an actin‐cross‐linking protein mainly expressed in heart and skeletal muscle, segregating in two families with autosomal‐dominant RCM. Affected individuals presented with heart failure due to severe diastolic dysfunction requiring heart transplantation in some cases. Histopathology of heart tissue from patients of both families showed cytoplasmic inclusions suggesting protein aggregates, which were filamin‐C specific for the p.S1624L by immunohistochemistry. Cytoplasmic aggregates were also observed in transfected myoblast cell lines expressing this mutant filamin‐C indicating further evidence for its pathogenicity. Thus, FLNC is a disease gene for autosomal‐dominant RCM and broadens the phenotype spectrum of filaminopathies.

[1]  U. Landmesser,et al.  Restrictive cardiomyopathy , 2017, Wiener klinische Wochenschrift.

[2]  J. Southern,et al.  BAG3 myofibrillar myopathy presenting with cardiomyopathy , 2015, Neuromuscular Disorders.

[3]  Ronald A. Li,et al.  Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy , 2015, Nature Communications.

[4]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[5]  Lorenzo L. Pesce,et al.  Targeted Analysis of Whole Genome Sequence Data to Diagnose Genetic Cardiomyopathy , 2014, Circulation. Cardiovascular genetics.

[6]  X. Puente,et al.  Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.

[7]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[8]  Paul M. K. Gordon,et al.  Titin mutation in familial restrictive cardiomyopathy. , 2014, International journal of cardiology.

[9]  J. Svendsen,et al.  The Novel Desmin Mutant p.A120D Impairs Filament Formation, Prevents Intercalated Disk Localization, and Causes Sudden Cardiac Death , 2013, Circulation. Cardiovascular genetics.

[10]  M. Tegenthoff,et al.  Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. , 2013, Journal of proteomics.

[11]  K. Bushby,et al.  Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  Christian Stephan,et al.  A Combined Laser Microdissection and Mass Spectrometry Approach Reveals New Disease Relevant Proteins Accumulating in Aggregates of Filaminopathy Patients* , 2012, Molecular & Cellular Proteomics.

[13]  J. Towbin,et al.  Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. , 2012, Human molecular genetics.

[14]  M. Heilemann,et al.  Dual Color Photoactivation Localization Microscopy of Cardiomyopathy-associated Desmin Mutants* , 2012, The Journal of Biological Chemistry.

[15]  Y. Capetanaki,et al.  Desmin‐related myopathy , 2011, Clinical genetics.

[16]  Robert H. Brown,et al.  Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. , 2011, American journal of human genetics.

[17]  U. Aebi,et al.  The nanomechanical properties of rat fibroblasts are modulated by interfering with the vimentin intermediate filament system. , 2011, Journal of structural biology.

[18]  M. P. van den Berg,et al.  Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy , 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[19]  S. Webber,et al.  Restrictive cardiomyopathy in childhood. , 2010, Heart failure clinics.

[20]  Sarika Sharma,et al.  Mutations in desmin's carboxy-terminal "tail" domain severely modify filament and network mechanics. , 2010, Journal of molecular biology.

[21]  N. Sebire,et al.  Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes , 2008, Heart.

[22]  A. Bozio,et al.  A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy. , 2008, Congenital heart disease.

[23]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[24]  A. Kaminska,et al.  Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. , 2007, International journal of cardiology.

[25]  L. Kunkel,et al.  Loss of FilaminC (FLNc) Results in Severe Defects in Myogenesis and Myotube Structure , 2006, Molecular and Cellular Biology.

[26]  J. Crosson,et al.  Infantile Restrictive Cardiomyopathy Resulting From a Mutation in the Cardiac Troponin T Gene , 2006, Pediatrics.

[27]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[28]  P. Elliott,et al.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.

[29]  J. Mate,et al.  A dysfunctional desmin mutation in a patient with severe generalized myopathy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Prevost,et al.  A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.

[31]  A. Keren,et al.  Assignment of patients into the classification of cardiomyopathies. , 1992, Circulation.

[32]  I. Nonaka,et al.  Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro. , 2012, Developmental biology.

[33]  A. Munir,et al.  Images in Cardiovascular Medicine , 2009 .

[34]  H. Goebel,et al.  Images in cardiovascular medicine. Giant right atrium in the setting of desmin-related restrictive cardiomyopathy. , 2006, Circulation.